CPC A61K 39/39541 (2013.01) [A61K 35/768 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 35/00 (2018.01); C07K 16/2818 (2013.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); C07K 2317/21 (2013.01); C07K 2317/24 (2013.01); C12N 2750/14332 (2013.01)] | 6 Claims |
1. A method of treating cancer comprising administering a pharmaceutical combination containing (a) parvovirus H-1 and (b) an anti-PD1 antibody or an anti-PD-L1 antibody.
|